TI
NGNE icon

Trexquant Investment’s Neurogene NGNE Stock Holding History

Trexquant Investment’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32M Buy
+73,762
New +$2.03M 0.01% 1133
2026
Q1 		– Sell
-43,323
Closed -$892K – 1956
2025
Q4 		$892K Buy
43,323
+3,840
+10% +$95.6K 0.01% 1215
2025
Q3 		$684K Buy
+39,483
New +$793K 0.01% 1252
2022
Q1 		– Sell
-2,436
Closed -$235K – 1613
2021
Q4 		$235K Buy
2,436
+721
+42% +$87.8K 0.01% 1054
2021
Q3 		$248K Buy
1,715
+1,004
+141% +$154K 0.02% 851
2021
Q2 		$131K Buy
+711
New +$157K 0.01% 990
2021
Q1 		– Sell
-607
Closed -$171K – 1350
2020
Q4 		$171K Buy
+607
New +$148K 0.02% 919

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Trexquant Investment's NGNE Position: Q2 2026 in Review

Trexquant Investment opened a new position in Neurogene (NGNE) in Q2 2026: 73,762 shares worth $2.32M. The stake represents 0.01% of the portfolio and ranks #1133 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in NGNE as recently as Q4 2025.

Trexquant Investment first reported a position in NGNE in Q4 2020 and has held it in 7 quarters since. 112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Trexquant Investment held 73,762 shares of Neurogene worth $2.32M as of Q2 2026.
  • Neurogene was a new Trexquant Investment position in Q2 2026.
  • Neurogene made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1133 holding.
  • Trexquant Investment first reported a position in Neurogene in Q4 2020 and has held it in 7 quarters since.
  • 112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.